With all the talk of reforming the FDA - speeding approvals, in particular - a new survey finds that most agency scientists believe political and corporate influence have sizeable weight on final regulatory decisions. And more than a quarter of agency scientists feel they are unable to openly express concerns about their “mission-driven” work without worrying about retaliation.
